|
2-[[(4R)-4-[(3R,5R,8R,9S,10S,13R,14S,17R)-3-Hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]acetic acid |
|
CHEBI:181179 |
|
This entity has been manually annotated by a third party.
|
|
MetaboLights
|
|
|
|
Molfile
XML
SDF
|
|
|
|
InChI=1S/C26H43NO4/c1-16(4-9-23(29)27-15-24(30)31)20-7-8-21-19-6-5-17-14-18(28)10-12-25(17,2)22(19)11-13-26(20,21)3/h16-22,28H,4-15H2,1-3H3,(H,27,29)(H,30,31) |
XBSQTYHEGZTYJE-UHFFFAOYSA-N |
OC1CC2C(C3C(C4C(C(CC4)C(CCC(=O)NCC(O)=O)C)(CC3)C)CC2)(CC1)C |
|
Outgoing
|
2-[[(4R)-4-[(3R,5R,8R,9S,10S,13R,14S,17R)-3-Hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]acetic acid
(CHEBI:181179)
is a
bile acid glycine conjugate
(CHEBI:36255)
|
|
2-[4-(3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoylamino]acetic acid
|
|